Physician profile
Andrew Lawrence
NPI 1306133129
$4,999.51
in general payments reported to CMS, 2019-2025
17 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $3,408 · 2021: $145 · 2022: $162 · 2023: $61.93 · 2024: $133 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $2,225.64 | 2019-2025 | |
| Arthrex, INC. | $2,152.12 | 2020 | |
| Abbott Laboratories | $123.10 | 2025 | Aveir |
| Endo Pharmaceuticals INC. | $95.33 | 2020-2024 | Xiaflex |
| Stryker Corporation | $46.55 | 2019 | |
| Radius Health, INC. | $45.11 | 2022 | |
| Kci USA, INC. | $40.62 | 2020 | |
| Ferring Pharmaceuticals INC. | $39.22 | 2019-2021 | |
| Zyla Life Sciences, INC. | $37.45 | 2019 | |
| Bioventus LLC | $36.98 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $28.41 | 2023 | Iovera, Zilretta |
| Solventum Corporation | $28.29 | 2025 | Prevena Restor Bellaform |
| Amgen INC. | $25.73 | 2024 | Evenity, Prolia |
| Endo USA, INC. | $22.50 | 2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $21.55 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $16.55 | 2024 | Crysvita |
| Mallinckrodt Enterprises LLC | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.